Sabine Venderbosch

1.4k total citations · 1 hit paper
13 papers, 1.0k citations indexed

About

Sabine Venderbosch is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Sabine Venderbosch has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in Sabine Venderbosch's work include Colorectal Cancer Treatments and Studies (10 papers), Genetic factors in colorectal cancer (9 papers) and Colorectal and Anal Carcinomas (4 papers). Sabine Venderbosch is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Genetic factors in colorectal cancer (9 papers) and Colorectal and Anal Carcinomas (4 papers). Sabine Venderbosch collaborates with scholars based in Netherlands, Germany and United States. Sabine Venderbosch's co-authors include Miriam Koopman, Cornelis J.A. Punt, Irıs D. Nagtegaal, Anton F. J. de Haan, Steven Teerenstra, David J. Fisher, Gerrit A. Meijer, Richard Kaplan, Philip Quirke and Bauke Ylstra and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Sabine Venderbosch

13 papers receiving 1.0k citations

Hit Papers

Mismatch Repair Status an... 2014 2026 2018 2022 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
    2014 534 citations Sabine Venderbosch, Irıs D. Nagtegaal et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabine Venderbosch Netherlands 9 890 541 271 217 203 13 1.0k
Christopher G. Smith United States 8 669 0.8× 456 0.8× 189 0.7× 151 0.7× 156 0.8× 15 811
Roger Sidhu United States 13 715 0.8× 248 0.5× 156 0.6× 388 1.8× 165 0.8× 29 904
Janna Christy‐Bittel United States 13 641 0.7× 301 0.6× 115 0.4× 221 1.0× 159 0.8× 20 820
Swantje Held Germany 17 920 1.0× 318 0.6× 230 0.8× 444 2.0× 210 1.0× 85 1.1k
Jaideep Sandhu United States 12 724 0.8× 338 0.6× 161 0.6× 213 1.0× 268 1.3× 29 929
Katie Southward United Kingdom 6 666 0.7× 435 0.8× 148 0.5× 200 0.9× 173 0.9× 6 809
A. Lamy France 6 646 0.7× 266 0.5× 98 0.4× 303 1.4× 138 0.7× 10 783
C. Barone Italy 7 516 0.6× 165 0.3× 179 0.7× 223 1.0× 145 0.7× 19 682
Frank Sinicrope Italy 4 932 1.0× 865 1.6× 242 0.9× 186 0.9× 251 1.2× 4 1.1k
Lin Shen China 11 577 0.6× 174 0.3× 164 0.6× 443 2.0× 163 0.8× 33 829

Countries citing papers authored by Sabine Venderbosch

Since Specialization
Citations

This map shows the geographic impact of Sabine Venderbosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Venderbosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Venderbosch more than expected).

Fields of papers citing papers by Sabine Venderbosch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Venderbosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Venderbosch. The network helps show where Sabine Venderbosch may publish in the future.

Co-authorship network of co-authors of Sabine Venderbosch

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Venderbosch. A scholar is included among the top collaborators of Sabine Venderbosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Venderbosch. Sabine Venderbosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Venderbosch, Sabine, Shannon van Vliet, Anton F. J. de Haan, et al.. (2015). EMAST Is Associated with a Poor Prognosis in Microsatellite Instable Metastatic Colorectal Cancer. PLoS ONE. 10(4). e0124538–e0124538. 27 indexed citations
2.
Venderbosch, Sabine, Shannon van Vliet, Femke Simmer, et al.. (2015). Mitochondrial microsatellite instability in patients with metastatic colorectal cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 466(5). 495–502. 8 indexed citations
3.
Simmer, Femke, Sabine Venderbosch, Jeroen R. Dijkstra, et al.. (2015). MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer. Oncotarget. 6(26). 22996–23007. 38 indexed citations
4.
Venderbosch, Sabine, Irıs D. Nagtegaal, Tim Maughan, et al.. (2014). Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies. Clinical Cancer Research. 20(20). 5322–5330. 534 indexed citations breakdown →
5.
Simmer, Femke, Jeroen R. Dijkstra, Sabine Venderbosch, et al.. (2014). Abstract 534: MicroRNA-143 is a putative predictive biomarker for 5-FU-based chemotherapy in patients with metastatic colorectal cancer. Cancer Research. 74(19_Supplement). 534–534. 1 indexed citations
6.
7.
Venderbosch, Sabine, Johannes H.W. de Wilt, Steven Teerenstra, et al.. (2012). Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature. Indian Journal of Surgical Oncology. 3(1). 57–65. 7 indexed citations
8.
Mekenkamp, Leonie J., Miriam Koopman, Jolien Tol, et al.. (2012). Mucinous adenocarcinomas: Poor prognosis in metastatic colorectal cancer. European Journal of Cancer. 48(4). 501–509. 129 indexed citations
9.
Venderbosch, Sabine, Johannes H.W. de Wilt, Steven Teerenstra, et al.. (2011). Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature. Annals of Surgical Oncology. 18(12). 3252–3260. 125 indexed citations
10.
Mekenkamp, Leonie J., Miriam Koopman, Steven Teerenstra, et al.. (2011). 6016 POSTER DISCUSSION Prognostic and Predictive Value of Mucinous Adenocarcinomas in Colorectal Cancer Patients Treated With Chemotherapy and Targeted Therapy. European Journal of Cancer. 47. S396–S396. 1 indexed citations
11.
Koopman, Miriam, Sabine Venderbosch, Harm van Tinteren, et al.. (2009). Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study. European Journal of Cancer. 45(11). 1999–2006. 70 indexed citations
12.
Koopman, Miriam, Sabine Venderbosch, Irıs D. Nagtegaal, J. Han van Krieken, & Cornelis J.A. Punt. (2009). A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?. European Journal of Cancer. 45(11). 1935–1949. 70 indexed citations
13.
Koopman, Miriam, Sabine Venderbosch, Ninja Antonini, J. Han van Krieken, & C.J.A. Punt. (2008). The correlation between ERCC1 expression and outcome of chemotherapy in patients with advanced colorectal cancer (ACC): A Dutch Colorectal Cancer Group study (DCCG). Journal of Clinical Oncology. 26(15_suppl). 11042–11042. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher G. Smith Breakdown of academic impact, for papers by Roger Sidhu Breakdown of academic impact, for papers by Janna Christy‐Bittel Breakdown of academic impact, for papers by Swantje Held Breakdown of academic impact, for papers by Jaideep Sandhu Breakdown of academic impact, for papers by Katie Southward Breakdown of academic impact, for papers by A. Lamy Breakdown of academic impact, for papers by C. Barone Breakdown of academic impact, for papers by Frank Sinicrope Breakdown of academic impact, for papers by Lin Shen
Rankless by CCL
2026